Sanofi halts phase 3 autoimmune trial early over lackluster data
Sanofi has stopped a phase 3 autoimmune clinical trial early after an interim analysis found the therapy was “unlikely…
Sanofi Halts Phase 3 CIDP Trial for Riliprubart Following Interim Review (SAN)
medical research woman microscope NEW SIZE ©Adobe Stock Images Sanofi (NASDAQ:SNY) said on Wednesday that it has decided…